We are live on ! Find out more
Squarepoint

Squarepoint Portfolio holdings

AUM $85.1B
1-Year Est. Return 20.93%
This Fund
S&P 500
This Quarter Est. Return
+4.39%
1 Year Est. Return
+20.93%
3 Year Est. Return
+51.38%
5 Year Est. Return
+34.63%
10 Year Est. Return
+146.23%
AUM
$5.74B
AUM Growth
+$541M
Cap. Flow
+$368M
Cap. Flow %
6.41%
Top 10 Hldgs %
14.68%
Holding
2,530
New
949
Increased
622
Reduced
470
Closed
486

Top Sells

Rank Stock Value
1
EWJ icon
iShares MSCI Japan ETF
EWJ
+$67M
2
INDA icon
iShares MSCI India ETF
INDA
+$55.1M
3
AAPL icon
Apple
AAPL
+$50.9M
4
INTU icon
Intuit
INTU
+$43.3M
5
LOW icon
Lowe's Companies
LOW
+$41.1M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 13.3%
2 Technology 11.38%
3 Healthcare 10.73%
4 Industrials 10.27%
5 Financials 8.74%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TTI icon
2001
TETRA Technologies
TTI
$1.23B
$60K ﹤0.01%
14,023
+2,874
+26% +$9.9K
PES
2002
DELISTED
Pioneer Energy Services Corp.
PES
$60K ﹤0.01%
19,648
-7,586
-28% -$16.6K
SREV
2003
DELISTED
ServiceSource International, Inc.
SREV
$59K ﹤0.01%
+19,029
New +$61.2K
ADXS
2004
DELISTED
Advaxis Inc
ADXS
$59K ﹤0.01%
+1,375
New +$69.6K
ONDK
2005
DELISTED
On Deck Capital, Inc.
ONDK
$59K ﹤0.01%
+10,307
New +$52.9K
AVP
2006
DELISTED
Avon Products, Inc.
AVP
$57K ﹤0.01%
26,357
-548,256
-95% -$1.18M
SB icon
2007
Safe Bulkers
SB
$781M
$56K ﹤0.01%
+17,187
New +$55.2K
AVXL icon
2008
Anavex Life Sciences
AVXL
$222M
$55K ﹤0.01%
+17,054
New +$67.1K
NH
2009
DELISTED
NantHealth, Inc
NH
$55K ﹤0.01%
+1,203
New +$63.8K
VSLR
2010
DELISTED
VIVINT SOLAR, INC.
VSLR
$54K ﹤0.01%
13,313
-12,134
-48% -$45K
AREX
2011
DELISTED
Approach Resources Inc.
AREX
$53K ﹤0.01%
+18,031
New +$44.5K
ASXC
2012
DELISTED
Asensus Surgical, Inc.
ASXC
$52K ﹤0.01%
2,054
-620
-23% -$19.1K
GNMK
2013
DELISTED
GenMark Diagnostics, Inc
GNMK
$52K ﹤0.01%
+12,480
New +$75.1K
LTS
2014
DELISTED
Ladenburg Thalmann Financial Services Inc
LTS
$52K ﹤0.01%
+16,459
New +$51.1K
PRTS icon
2015
CarParts.com
PRTS
$42.8M
$51K ﹤0.01%
+2,010
New +$50K
XRM
2016
DELISTED
Xerium Technologies Inc (new)
XRM
$50K ﹤0.01%
+11,802
New +$51.9K
CVEO icon
2017
Civeo
CVEO
$379M
$49K ﹤0.01%
1,506
-3,654
-71% -$100K
VIVS
2018
VivoSim Labs
VIVS
$1.46M
$48K ﹤0.01%
+149
New +$55.4K
INFI
2019
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
$48K ﹤0.01%
23,560
-92,200
-80% -$191K
ICD
2020
DELISTED
Independence Contract Drilling, Inc.
ICD
$47K ﹤0.01%
+594
New +$43.3K
DRD
2021
DRDGold
DRD
$1.82B
$45K ﹤0.01%
13,946
-1,815
-12% -$6.22K
AQMS icon
2022
Aqua Metals
AQMS
$9.63M
$43K ﹤0.01%
+101
New +$76.3K
RAD
2023
DELISTED
Rite Aid Corporation
RAD
$43K ﹤0.01%
+1,083
New +$38.7K
MGNI icon
2024
Magnite
MGNI
$2.65B
$41K ﹤0.01%
+21,964
New +$54.9K
PACB icon
2025
Pacific Biosciences
PACB
$422M
$40K ﹤0.01%
+14,977
New +$52.4K

Similar funds

Squarepoint's Q4 2017 Portfolio in Review

As of Q4 2017, Squarepoint held 2,530 positions worth $5.74B, up 10% from $5.2B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Squarepoint deployed $368M of net new capital in Q4 2017, opening 949 new positions and adding to 622 existing holdings. Its largest new stake was Boston Scientific: 1,494,796 shares worth $37.1M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 13% of assets, up from 12% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was Apple, an estimated $50.9M trimmed.

  • Squarepoint's largest Q4 2017 buy was Boston Scientific: 1,494,796 shares worth $37.1M.
  • Squarepoint added most to iShares Core MSCI Emerging Markets ETF in Q4 2017, an estimated $203M increase.
  • Squarepoint's biggest Q4 2017 reduction was Apple, cutting an estimated $50.9M.
  • Squarepoint fully exited iShares MSCI Japan ETF in Q4 2017, selling an estimated $67M.
  • Squarepoint's ten largest holdings make up 15% of its $5.74B portfolio in Q4 2017.
  • Squarepoint opened 949 new positions and closed 486 in Q4 2017.
  • Squarepoint's portfolio value rose 10% quarter-over-quarter to $5.74B.

Based on Squarepoint's 13F filing for Q4 2017, filed 14 Feb 2018.